ArticleJournal of personalized medicine2023

Long-Term Safety of Omalizumab in Children with Asthma and/or Chronic Spontaneous Urticaria: A 4-Year Prospective Study in Real Life.

Francesca Galletta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.